|3.96|| +0.06 / +1.54%|
Cesca Therapeutics, Inc. engages in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It operates through the Clinical Development Division and Device Division business segments. The Clinical Development Division segment involves in developing autologous stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology, and orthopedic markets. The Device Division segment includes development and commercialization of automated technologies for cell-based therapeutics and bio-processing. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.
|Xiao Chun Xu||Chairman & Chief Executive Officer|
|Vivian H. Liu||Chief Operating Officer & Director|
|Jeffery Cauble||Principal Financial & Accounting Officer|
|Philip H. Coelho||Chief Technology Officer|
|Dalip Sethi||Senior Director-Research & Development|